DK1067958T3 - Behandling af hjertehypertrofi - Google Patents

Behandling af hjertehypertrofi

Info

Publication number
DK1067958T3
DK1067958T3 DK99912711T DK99912711T DK1067958T3 DK 1067958 T3 DK1067958 T3 DK 1067958T3 DK 99912711 T DK99912711 T DK 99912711T DK 99912711 T DK99912711 T DK 99912711T DK 1067958 T3 DK1067958 T3 DK 1067958T3
Authority
DK
Denmark
Prior art keywords
treatment
cardiac hypertrophy
hypertrophy
cardiac
Prior art date
Application number
DK99912711T
Other languages
Danish (da)
English (en)
Inventor
Hongkui Jin
Hsienwie Lu
Nicholas J Paoni
Renhui Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1067958T3 publication Critical patent/DK1067958T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK99912711T 1998-04-02 1999-03-19 Behandling af hjertehypertrofi DK1067958T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8044898P 1998-04-02 1998-04-02

Publications (1)

Publication Number Publication Date
DK1067958T3 true DK1067958T3 (da) 2006-11-06

Family

ID=22157456

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99912711T DK1067958T3 (da) 1998-04-02 1999-03-19 Behandling af hjertehypertrofi
DK06013719T DK1702623T3 (da) 1998-04-02 1999-03-19 Anvendelse af interferon-gamma til behandling af hjertehypertrofi

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06013719T DK1702623T3 (da) 1998-04-02 1999-03-19 Anvendelse af interferon-gamma til behandling af hjertehypertrofi

Country Status (17)

Country Link
US (2) US6187304B1 (cg-RX-API-DMAC7.html)
EP (2) EP1067958B1 (cg-RX-API-DMAC7.html)
JP (2) JP5030329B2 (cg-RX-API-DMAC7.html)
CN (1) CN1201814C (cg-RX-API-DMAC7.html)
AR (1) AR018174A1 (cg-RX-API-DMAC7.html)
AT (2) ATE332144T1 (cg-RX-API-DMAC7.html)
AU (1) AU757910B2 (cg-RX-API-DMAC7.html)
BR (1) BR9909422A (cg-RX-API-DMAC7.html)
CA (1) CA2325442C (cg-RX-API-DMAC7.html)
DE (2) DE69939723D1 (cg-RX-API-DMAC7.html)
DK (2) DK1067958T3 (cg-RX-API-DMAC7.html)
ES (2) ES2314786T3 (cg-RX-API-DMAC7.html)
IL (1) IL138812A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ506854A (cg-RX-API-DMAC7.html)
TW (1) TWI243682B (cg-RX-API-DMAC7.html)
WO (1) WO1999051260A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200004854B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192659A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
BR9909422A (pt) * 1998-04-02 2001-09-11 Genentech Inc Método para tratamento de hipertrofia cardìaca, método para preparação de composição farmacêutica para o tratamento de hipertrofia cardìaca e seu produto farmacêutico
ATE376837T1 (de) * 1999-07-12 2007-11-15 Genentech Inc Stimulierung oder hemmung von angiogenese und herzvaskularisierung mit tumor nekrose faktor ligand/rezeptor homologen
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
US7625584B2 (en) * 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US8110218B2 (en) * 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
US20050079156A1 (en) * 2001-11-06 2005-04-14 Grace Wong Method of treating endometreosis
WO2003068260A1 (fr) * 2002-02-14 2003-08-21 Chugai Seiyaku Kabushiki Kaisha Produits pharmaceutiques en solution contenant des anticorps
KR101160780B1 (ko) * 2002-08-29 2012-06-27 산텐 세이야꾸 가부시키가이샤 Rho 키나아제 억제제 및 프로스타글란딘류를 포함하는 녹내장 치료제
WO2004045644A1 (ja) * 2002-11-18 2004-06-03 Santen Pharmaceutical Co., Ltd. Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
WO2009154770A2 (en) * 2008-06-18 2009-12-23 The Texas A & M University System Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
USD647411S1 (en) 2011-01-12 2011-10-25 Rain Bird Corporation Water timer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096705A (en) 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
US5582824A (en) 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
AU561343B2 (en) 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US4929544A (en) 1982-04-23 1990-05-29 Sri International Reagents, methods, and test kit for diagnosing/monitoring cancer in humans
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4944941A (en) 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
SE462364B (sv) 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
DK0502997T3 (da) 1989-12-01 1995-07-17 Childrens Medical Center Behandling af atopiske sygdomme med gamma-interferon
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5573762A (en) 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
WO1997007820A1 (fr) * 1995-08-30 1997-03-06 Toray Industries, Inc. Remede destine aux maladies cardiaques
BR9909422A (pt) * 1998-04-02 2001-09-11 Genentech Inc Método para tratamento de hipertrofia cardìaca, método para preparação de composição farmacêutica para o tratamento de hipertrofia cardìaca e seu produto farmacêutico

Also Published As

Publication number Publication date
DK1702623T3 (da) 2009-01-19
ES2314786T3 (es) 2009-03-16
EP1702623A3 (en) 2007-01-10
TWI243682B (en) 2005-11-21
AU3102499A (en) 1999-10-25
CN1201814C (zh) 2005-05-18
NZ506854A (en) 2003-07-25
ZA200004854B (en) 2001-09-26
ES2267258T3 (es) 2007-03-01
CA2325442C (en) 2011-10-11
EP1702623B1 (en) 2008-10-08
JP2002510645A (ja) 2002-04-09
EP1067958A2 (en) 2001-01-17
IL138812A0 (en) 2001-10-31
ATE410181T1 (de) 2008-10-15
JP2009256375A (ja) 2009-11-05
EP1702623A2 (en) 2006-09-20
US6187304B1 (en) 2001-02-13
WO1999051260A3 (en) 1999-12-09
EP1067958B1 (en) 2006-07-05
HK1036019A1 (en) 2001-12-21
JP5030329B2 (ja) 2012-09-19
ATE332144T1 (de) 2006-07-15
US6989364B1 (en) 2006-01-24
HK1099197A1 (en) 2007-08-10
DE69932235T2 (de) 2007-06-14
WO1999051260A2 (en) 1999-10-14
DE69932235D1 (de) 2006-08-17
CN1300221A (zh) 2001-06-20
AU757910B2 (en) 2003-03-13
AR018174A1 (es) 2001-10-31
CA2325442A1 (en) 1999-10-14
DE69939723D1 (de) 2008-11-20
BR9909422A (pt) 2001-09-11

Similar Documents

Publication Publication Date Title
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DK0914103T3 (da) Behandling af hæmoglobinopati
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DK0664957T3 (da) Behandling af fjerkræ
DK1183345T3 (da) Styret evolution af mikroorganismer
ID27092A (id) Pembuatan ftalat anhidrida
PT1161420E (pt) Fungicidas de pirazol-carboxanilidas
DE69926385D1 (de) Behandlung von geweben
FI20000863A0 (fi) Uusi hoitomenetelmä
FR2780269B1 (fr) Implant rachidien
EP1061866A4 (en) KNOCHENXENOTRANSPLANTATE
EP0996433A4 (en) Methods for treatment of conditions associated with lactosylceramide
DE60019960D1 (de) Herstellung von isobutencopolymere
EP1117431A4 (en) TREATMENT OF ACIDOSIS
DK1702623T3 (da) Anvendelse af interferon-gamma til behandling af hjertehypertrofi
DE69935165D1 (de) Herstellung von polyolefin
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DE60026821D1 (de) Behandlung von bohrspülung
ID30023A (id) Kombinasi senyawa aktif fungisida
DE60007111D1 (de) Herstellung von ausgewählten fluorolefinen
ID27298A (id) Peningkatan hidrolik komponen-komponen
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20003529D0 (no) Behandling av dyskinesi
ID30381A (id) Penggunaan arilalkanoilpiridazina